CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,474 | -20.3% | 869,637 | -1.4% | 0.01% | -14.3% |
| Q2 2023 | $49,537 | -0.7% | 882,375 | -20.0% | 0.01% | 0.0% |
| Q1 2023 | $49,877 | +9.3% | 1,102,721 | -1.8% | 0.01% | 0.0% |
| Q4 2022 | $45,644 | -99.9% | 1,122,848 | -5.4% | 0.01% | -46.2% |
| Q3 2022 | $77,602,000 | -57.6% | 1,187,462 | -60.6% | 0.01% | -43.5% |
| Q2 2022 | $183,194,000 | +150.3% | 3,014,551 | +158.5% | 0.02% | +228.6% |
| Q1 2022 | $73,197,000 | -11.5% | 1,166,114 | +6.9% | 0.01% | 0.0% |
| Q4 2021 | $82,662,000 | -37.7% | 1,090,813 | -7.9% | 0.01% | -41.7% |
| Q3 2021 | $132,607,000 | -31.1% | 1,184,729 | -0.4% | 0.01% | -33.3% |
| Q2 2021 | $192,531,000 | +21.7% | 1,189,273 | -8.4% | 0.02% | +12.5% |
| Q1 2021 | $158,201,000 | -41.8% | 1,298,329 | -26.8% | 0.02% | -42.9% |
| Q4 2020 | $271,684,000 | +99.2% | 1,774,436 | +8.8% | 0.03% | +75.0% |
| Q3 2020 | $136,411,000 | +35.0% | 1,630,932 | +18.6% | 0.02% | +23.1% |
| Q2 2020 | $101,073,000 | +135.7% | 1,375,327 | +36.0% | 0.01% | +85.7% |
| Q1 2020 | $42,885,000 | -36.6% | 1,011,203 | -8.9% | 0.01% | -22.2% |
| Q4 2019 | $67,615,000 | +136.2% | 1,110,172 | +59.0% | 0.01% | +125.0% |
| Q3 2019 | $28,621,000 | -17.8% | 698,243 | -5.5% | 0.00% | -20.0% |
| Q2 2019 | $34,801,000 | +57.7% | 738,869 | +19.6% | 0.01% | +66.7% |
| Q1 2019 | $22,064,000 | +25.4% | 617,693 | +0.3% | 0.00% | 0.0% |
| Q4 2018 | $17,595,000 | +95.8% | 615,848 | +203.9% | 0.00% | +200.0% |
| Q3 2018 | $8,987,000 | -23.4% | 202,636 | +1.5% | 0.00% | -50.0% |
| Q2 2018 | $11,727,000 | +333.2% | 199,575 | +31.7% | 0.00% | – |
| Q3 2017 | $2,707,000 | – | 151,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |